Abstract:Background: Candida species are opportunistic pathogenic fungi that colonize in the human body. They may cause diseases ranging from non-life-threatening mucosal Candida infections to life-threatening invasive candidiasis among people with the aggressive use of immunosuppressive agents, cytotoxic therapies, treatment with broad-spectrum antifungal agents, prolonged central venous catheterization, total parenteral nutrition, AIDS, diabetes, and drug abuse. Objectives: The aim of this study was to describe the distribution and antifungal susceptibility of clinical Candida isolates obtained from sterile fluids of patients who suffered from candidiasis from 2008 to 2010. Methods: Vitek2 YST, CHROMagar Candida medium, and multiple PCR were used to identify the Candida species. The susceptibility testing to seven common antifungal agents, including amphotericin B, flucytosine, fluconazole, itraconazole, ketoconazole, clotrimazole, and nystatin, was performed using the methodology recommended in the M27-A3 document of the clinical and laboratory standards institute (CLSI). Results: A total of 149 clinical Candida isolates were obtained from sterile fluids at a hospital in China. Within these isolates, Candida albicans was the most predominant species (47.7%), followed by C. glabrata (26.8%) and C. tropicalis (13.4%). The sources of fungal isolates were urine (75.8%), blood (16.8%), drainage liquid (4%), hydrothorax and ascites (2%), cerebrospinal fluid (0.7%), and succus prostaticus (0.7%). All of the Candida isolates were susceptible to amphotericin B. In addition, 27.5% of the isolates were resistant to ketoconazole, 22.1% to itraconazole, and 17.4% to fluconazole. Furthermore, 16.8% (25/149) of the isolates exhibited a cross-resistance to azoles. Interestingly, we found one flucytosine-resistant C. albicans isolated from urine. Conclusions: Our findings indicate that a better preventive management and limited use of azole drugs are needed for Candida infections and further research is indispensable to identify cross-resistance mechanisms of azoles.

Study of Common Pathogen and Antifungal Susceptibility Testing in Pediatric Patients with Fungal Infection

Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: an Update from the CHIF-NET Study

Nosocomial Fungus Infection:A Clinical Analysis

Analysis of antifungal susceptibility in vitro and fungi distribution in clinics

Yeast Colonization and Drug Susceptibility Pattern in the Pediatric Patients With Neutropenia

Study on drug resistance of fungi isolated from infected patients in hospital

Clinical characteristics and drug resistance of 176 strains of candida isolated from children with blood infections

Clinical Distribution and Drug Resistance Analysis of 978 Clinical Fungus Strains

The separation and identification of clinical deep fungus and the analysis of drug susceptibility results

Prevalence and Resistance Characteristics of Fungal Infection in Intensive Care Unit

Fungal infections in tumor patients and analysis of drug resistance

Fungus Identification and Antibiotics Susceptibility Test in Department of Respiration

Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans isolates from pediatric patients in China.

Clinical Fungal Infections and Their Drug Resistance

Retrospective analysis of 130 cases of deep fungal infection in blood samples: fungus identification and drug sensitive test

Distribution and Antimicrobial Resistance of Pathogenic Fungi Causing Urinary Tract Infections

Fungemia: A Retrospective Clinical Analysis of 17 Patients

Analysis of Deep Fungals Infection and Drug Resistance

Clinical Characteristic and Antifungal Drug Sensitivity of Candida Parapsilosis Infections in Blood of Neonates

Species identification and antifungal susceptibility of 128 strains of yeast fungi

In Vitro Antidrug Susceptibility Testing of Candida Species Isolated from Aseptic Body Fluids